New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
Low-density lipoprotein cholesterol (LDL-C)-lowering therapy that increases LDL receptor expression in several ways robustly reduces the risk of atherosclerotic cardiovascular disease (CVD). However, a substantial risk of CVD still remains after intensive LDL-C reduction, which requires new treatmen...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Korean Society of Lipid and Atherosclerosis
2023-01-01
|
| Sarja: | Journal of Lipid and Atherosclerosis |
| Aiheet: | |
| Linkit: | https://www.e-jla.org/search.php?where=aview&id=10.12997/jla.2023.12.1.23&code=9992JLA&vmode=FULL |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|